Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/10/13 → 6/30/16 |
Funding
- Naprogenix: $299,760.00
SBIR Phase II: Selection-Driven Plant Metabolites for Treatment of CNS Diseases
- Gerhardt, Greg (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 9/10/13 → 6/30/16 |